Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights Transcript
Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights - Slideshow (NASDAQ:AUTL) 2026-04-08
Gli EPS di Autolus Therapeutics hanno mancato le aspettative per 0,09$, il fatturato appena sotto le previsioni